Use of cookies by
Norton Rose Fulbright
We use cookies to deliver our online services. Details and instructions on how to disable those cookies are set out at nortonrosefulbright.com/cookies-policy. By continuing to use this website you agree to our use of our cookies unless you have disabled them.
Statement of Abbe David Lowell on the Verdict in Dr. Melgen's Case | Norton Rose Fulbright

Statement of Abbe David Lowell on the Verdict in Dr. Melgen's Case

April 28, 2017

Contacts

I have spoken to Senator Menendez and he is saddened for his long-time friend and is thinking of his family on this difficult day.

As we have known for the past two years, the issues involved in Dr. Melgen's case in South Florida had no bearing on the allegations made against the Senator, and this verdict will have no impact on him.

Dr. Melgen's case focused solely on the day-to-day operations of his medical practice and the private care of his patients – specifics of which the Senator could not be aware, nor has it ever been suggested otherwise.

From the beginning, Senator Menendez has been clear that he has always acted in accordance with the law and in his appropriate legislative oversight role as a member of Congress. When all of the facts are heard, he is fully confident that a jury will agree and he will be vindicated.

About Chadbourne & Parke LLP

For more than a century, Chadbourne & Parke has counseled innovators around the world. We are a full-service law firm that leverages the extraordinary talent from our network of international offices to offer the highest caliber client service in more than 80 countries and across every region on the globe. Today, we are recognized internationally for our groundbreaking work in emerging economies and our deep experience in pharmaceutical collaboration transactions, energy and infrastructure, corporate and finance transactions, international disputes, and bankruptcy and financial restructuring.

Originally prepared by Chadbourne & Parke. Chadbourne & Parke combined with Norton Rose Fulbright US LLP on June 30, 2017 and is now known as Norton Rose Fulbright US LLP.